biotin dextran amines (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
92
Structured Review
Vector Laboratories
biotin dextran amines
Biotin Dextran Amines, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 92/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bda+fluorescein/Biotinylated+Dextran+Amine-Fluorescein%2C+10%2C000+MW+(BDA-10KF)/pmc03906221-46-3-38
Average 92 stars, based on 14 article reviews
Biotin Dextran Amines, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 92/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bda+fluorescein/Biotinylated+Dextran+Amine-Fluorescein%2C+10%2C000+MW+(BDA-10KF)/pmc03906221-46-3-38
Average 92 stars, based on 14 article reviews
biotin dextran amines - by Bioz Stars,
2026-10
92/100 stars
Images
Related Articles
Anterograde Tracing:Article Title: Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury. Article Snippet: Evidence suggested that glycogen synthase kinase-3β (GSK-3β) is involved in Nogo-66 inhibiting axonal regeneration in vitro, but its effect in vivo was poorly understood.. We showed that stereotactic injection of shRNA GSK-3β-adeno associated virus (GSK-3β-AAV) diminished syringomyelia and promoted axonal regeneration after spinal cord injury (SCI), using stereotactic injection of shRNA GSK-3β-AAV (tested with Western blotting and RT-PCR) into the sensorimotor cortex of rats with SCI and by the detection of biotin dextran amine (BDA)-labeled axonal regeneration.. We also determined the right position to inject into the sensorimotor cortex. Injection:Article Title: Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury. Article Snippet: Evidence suggested that glycogen synthase kinase-3β (GSK-3β) is involved in Nogo-66 inhibiting axonal regeneration in vitro, but its effect in vivo was poorly understood.. We showed that stereotactic injection of shRNA GSK-3β-adeno associated virus (GSK-3β-AAV) diminished syringomyelia and promoted axonal regeneration after spinal cord injury (SCI), using stereotactic injection of shRNA GSK-3β-AAV (tested with Western blotting and RT-PCR) into the sensorimotor cortex of rats with SCI and by the detection of biotin dextran amine (BDA)-labeled axonal regeneration.. We also determined the right position to inject into the sensorimotor cortex. Bioprocessing:Article Title: Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury. Article Snippet: Evidence suggested that glycogen synthase kinase-3β (GSK-3β) is involved in Nogo-66 inhibiting axonal regeneration in vitro, but its effect in vivo was poorly understood.. We showed that stereotactic injection of shRNA GSK-3β-adeno associated virus (GSK-3β-AAV) diminished syringomyelia and promoted axonal regeneration after spinal cord injury (SCI), using stereotactic injection of shRNA GSK-3β-AAV (tested with Western blotting and RT-PCR) into the sensorimotor cortex of rats with SCI and by the detection of biotin dextran amine (BDA)-labeled axonal regeneration.. We also determined the right position to inject into the sensorimotor cortex. |